Bioxyne (ASX:BXN) received commitments to raise AU$3 million via the placing of 120 million new shares at AU$0.025 apiece, according to a Friday Australian bourse filing.
It will also issue 60 million options on the basis of one option for every two new shares, with an exercise price of AU$0.05 and an expiry date of two years from the date of issue.
It will use the proceeds to support its expansion into European markets as well as the establishment and certification of medical cannabis manufacturing facilities in the UK and Czechia.
Its directors will participate in the amount of AU$110,000, subject to shareholder approval.
Alpine Capital was the sole lead manager and book runner to the placement.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。